Ivelin S. Georgiev
- Virology top 0.5%
- HIV Research and Treatment 39
- Immunology top 2%
- Immune Cell Function and Interaction 17
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment 14
-
- Monoclonal and Polyclonal Antibodies Research 26
- Molecular Biology top 5%
- Glycosylation and Glycoproteins Research 10
- Protein Structure and Dynamics 8
- RNA and protein synthesis mechanisms 8
-
- Cytomegalovirus and herpesvirus research 9
- Co-authors
- Bruce R. DonaldPeter D. KwongTongqing ZhouAmy C. AndersonJohn R. MascolaMichel C. NussenzweigGary J. NabelJohannes F. Scheid
- Partner nations
- United StatesSouth AfricaFrance
In The Last Decade
Ivelin S. Georgiev
74 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Virology 1.6k
- Immunology 1.1k
- Infectious Diseases 934
- Radiology, Nuclear Medicine and Imaging 822
- Molecular Biology 1.5k
Countries citing papers authored by Ivelin S. Georgiev
This map shows the geographic impact of Ivelin S. Georgiev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivelin S. Georgiev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivelin S. Georgiev more than expected).
Fields of papers citing papers by Ivelin S. Georgiev
This network shows the impact of papers produced by Ivelin S. Georgiev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivelin S. Georgiev. The network helps show where Ivelin S. Georgiev may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ivelin S. Georgiev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 27 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 29 | |
| 7 | 2020 | 4 | |
| 8 | 2019 | 24 | |
| 9 | 2019 | 27 | |
| 10 | 2018 | 61 | |
| 11 | 2017 | 16 | |
| 12 | 2016 | 10 | |
| 13 | 2014 | 1 | |
| 14 | 2013 | 86 | |
| 15 | 2012 | 28 | |
| 16 | 2011 | 46 | |
| 17 | 2011 | 12 | |
| 18 | 2010 | 92 | |
| 19 | Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01breakdown → | 2010 | 821 |
| 20 | 2008 | 65 |
About Ivelin S. Georgiev
Ivelin S. Georgiev is a scholar working on Virology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging, having authored 76 papers that have together received 3.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (39 papers), Monoclonal and Polyclonal Antibodies Research (26 papers), Immune Cell Function and Interaction (17 papers), HIV/AIDS drug development and treatment (14 papers), Glycosylation and Glycoproteins Research (10 papers), Cytomegalovirus and herpesvirus research (9 papers), Protein Structure and Dynamics (8 papers) and RNA and protein synthesis mechanisms (8 papers). The work is most often cited by research in Virology (1.6k citations), Immunology (1.1k citations) and Infectious Diseases (934 citations). Ivelin S. Georgiev has collaborated with scholars based in United States, South Africa and France. Frequent co-authors include Bruce R. Donald, Peter D. Kwong, Tongqing Zhou, Amy C. Anderson, John R. Mascola, Michel C. Nussenzweig, Gary J. Nabel, Johannes F. Scheid, Yongping Yang and Ryan Lilien.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.